BioAdaptives, Inc. announced the Company's formation of TizHemp, a new operating division to concentrate efforts on wellness-related hemp-based products, and the appointment of Mr. Ron Lambrecht as the Company's new Chief Financial Officer, reporting to the CEO, President, and Board, effective 1 October, 2019. For the past 25 years Mr. Lambrecht has operated a financial services business in addition to facilitating a number of technology acquisitions and joint venture transactions.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0005 USD | -16.67% | 0.00% | 0.00% |
05-17 | BioAdaptives, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-10 | BioAdaptives, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
0.00% | 616K | |
+13.97% | 8.2B | |
+5.29% | 7.61B | |
+0.60% | 5.95B | |
-6.04% | 3.72B | |
-10.75% | 3.57B | |
-7.53% | 1.27B | |
-29.55% | 1.07B | |
+14.57% | 988M | |
-12.85% | 890M |
- Stock Market
- Equities
- BDPT Stock
- News BioAdaptives, Inc.
- BioAdaptives, Inc. Announces Tizhemp, a New Hemp-Product Division; Appoints Ron Lambrecht as New CFO